Bioresorbable Polymers Market by Product Type (Polycaprolactone, Polyglycolic Acid, Polylactic Acid), Application (Drug Delivery, Orthopedics) - Global Forecast 2023-2030
The Bioresorbable Polymers Market is projected to reach USD 1,819.30 million by 2030 from USD 822.94 million in 2022, at a CAGR of 10.42% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bioresorbable Polymers Market.
- Based on Product Type, market is studied across Polycaprolactone, Polyglycolic Acid, Polylactic Acid, Polysaccharides, and Proteins. The Polycaprolactone commanded largest market share of 36.45% in 2022, followed by Polyglycolic Acid.
- Based on Application, market is studied across Drug Delivery and Orthopedics. The Drug Delivery is further studied across Oral and Parenteral. The Orthopedics is further studied across Hip, Knee, Spine, and Trauma. The Drug Delivery commanded largest market share of 34.12% in 2022, followed by Orthopedics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.12% in 2022, followed by Americas.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Bioresorbable Polymers Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Bioresorbable Polymers Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Bioresorbable Polymers Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek LLC, Acuro Organics Limited, Aduro Biopolymers LP, Advanced Polymer Materials Inc., Anhui Jumei Biological Technology Co., Ltd., Ashland Inc., Avantium N.V., BMG Incorporated, CD Bioparticles, Celares GmbH, ChitoLytic, Corbion NV, Evonik Industries AG, Foster Corporation, Futerro Group, Galatea Surgical, Inc., Gebrüder Martin GmbH & Co. KG, Goodfellow Cambridge Ltd., Huizhou Foryou Medical Devices Co., Ltd., Koninklijke DSM N.V., MAST Biosurgery, MCG BioComposites, LLC, Merck KGaA, Mitsui & Co., Ltd., Musashino Chemical Laboratory, Ltd., Nanjing Jiayi Sunway Chemical Co., Ltd., Nanosoft Polymers, NatureWorks LLC, Nomisma Healthcare Pvt. Ltd., Otto Chemie Pvt. Ltd., PBI Performance Products, Inc., Plastics New Zealand, Poly-Med Incorporated, PolyClean Technologies, Inc., PolyNovo Limited, Polysciences, Inc., Putnam Plastics, QINGDAO SOCO NEW MATERIAL CO., LTD., REVA Medical, LLC, Rivika Bio Industries Pvt. Ltd., SEQENS SAS, Solanyl Biopolymers Inc., SpecialChem S.A., Stahl Holdings B.V., Stepan Company, Torise Biomaterials Co.,Ltd., UBQ Materials Ltd., Univar Solutions Inc., Vibha Ecopac Pvt Ltd., and Zeus Industrial Products, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Bioresorbable Polymers Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Bioresorbable Polymers Market?
- What is the competitive strategic window for identifying opportunities in the Bioresorbable Polymers Market?
- What are the latest technology trends and regulatory frameworks in the Bioresorbable Polymers Market?
- What is the market share of the leading vendors in the Bioresorbable Polymers Market?
- Which modes and strategic moves are suitable for entering the Bioresorbable Polymers Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Bioresorbable Polymers Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Surging availability of orthopedic devices with usage of bioresorbable polymers
- 5.1.1.2. Favorable reimbursement policies for several surgical procedures
- 5.1.1.3. Growing adoption of bioresorbable polymers for polymeric drug delivery and 3D printed medical implants
- 5.1.2. Restraints
- 5.1.2.1. Availability of cheap and conventional bioresorbable polymers
- 5.1.3. Opportunities
- 5.1.3.1. Supportive government initiatives in research and development of bio-based bioresorbable polymer
- 5.1.3.2. Rising technological advances in orthopedic implants and surgical devices
- 5.1.4. Challenges
- 5.1.4.1. Barriers associated with the bioresorbable packaging
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Bioresorbable Polymers Market, by Product Type
- 6.1. Introduction
- 6.2. Polycaprolactone
- 6.3. Polyglycolic Acid
- 6.4. Polylactic Acid
- 6.5. Polysaccharides
- 6.6. Proteins
- 7. Bioresorbable Polymers Market, by Application
- 7.1. Introduction
- 7.2. Drug Delivery
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3. Orthopedics
- 7.4.1. Hip
- 7.4.2. Knee
- 7.4.3. Spine
- 7.4.4. Trauma
- 8. Americas Bioresorbable Polymers Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Bioresorbable Polymers Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Bioresorbable Polymers Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 11.3.1. Merger & Acquisition
- 11.3.1.1. Collagen matrix acquires polyganics
- 11.3.1.2. Technip energies acquires Biosuccinium technology from DSM for bio-sourced and fully biodegradable polymers production
- 11.3.2. Agreement, Collaboration, & Partnership
- 11.3.2.1. Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
- 11.3.3. New Product Launch & Enhancement
- 11.3.3.1. Amerigo scientific launches polycaprolactone for bioprinting
- 11.3.4. Investment & Funding
- 11.3.4.1. Evonik backs Allay's development of pain therapy implants
- 11.3.4.2. Biotech startup String Bio raises $20M in funding from Woodside Energy Group, others
- 11.3.5. Award, Recognition, & Expansion
- 11.3.5.1. Ashland expands bioresorbable development site in Ireland
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. 3D Biotek LLC
- 12.1.2. Acuro Organics Limited
- 12.1.3. Aduro Biopolymers LP
- 12.1.4. Advanced Polymer Materials Inc.
- 12.1.5. Anhui Jumei Biological Technology Co., Ltd.
- 12.1.6. Ashland Inc.
- 12.1.7. Avantium N.V.
- 12.1.8. BMG Incorporated
- 12.1.9. CD Bioparticles
- 12.1.10. Celares GmbH
- 12.1.11. ChitoLytic
- 12.1.12. Corbion NV
- 12.1.13. Evonik Industries AG
- 12.1.14. Foster Corporation
- 12.1.15. Futerro Group
- 12.1.16. Galatea Surgical, Inc.
- 12.1.17. Gebrüder Martin GmbH & Co. KG
- 12.1.18. Goodfellow Cambridge Ltd.
- 12.1.19. Huizhou Foryou Medical Devices Co., Ltd.
- 12.1.20. Koninklijke DSM N.V.
- 12.1.21. MAST Biosurgery
- 12.1.22. MCG BioComposites, LLC
- 12.1.23. Merck KGaA
- 12.1.24. Mitsui & Co., Ltd.
- 12.1.25. Musashino Chemical Laboratory, Ltd.
- 12.1.26. Nanjing Jiayi Sunway Chemical Co., Ltd.
- 12.1.27. Nanosoft Polymers
- 12.1.28. NatureWorks LLC
- 12.1.29. Nomisma Healthcare Pvt. Ltd.
- 12.1.30. Otto Chemie Pvt. Ltd.
- 12.1.31. PBI Performance Products, Inc.
- 12.1.32. Plastics New Zealand
- 12.1.33. Poly-Med Incorporated
- 12.1.34. PolyClean Technologies, Inc.
- 12.1.35. PolyNovo Limited
- 12.1.36. Polysciences, Inc.
- 12.1.37. Putnam Plastics
- 12.1.38. QINGDAO SOCO NEW MATERIAL CO., LTD.
- 12.1.39. REVA Medical, LLC
- 12.1.40. Rivika Bio Industries Pvt. Ltd.
- 12.1.41. SEQENS SAS
- 12.1.42. Solanyl Biopolymers Inc.
- 12.1.43. SpecialChem S.A.
- 12.1.44. Stahl Holdings B.V.
- 12.1.45. Stepan Company
- 12.1.46. Torise Biomaterials Co.,Ltd.
- 12.1.47. UBQ Materials Ltd.
- 12.1.48. Univar Solutions Inc.
- 12.1.49. Vibha Ecopac Pvt Ltd.
- 12.1.50. Zeus Industrial Products, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook